Biomax Provides AI-Based Semantic Search Platform AILANI and Supports COVID-19 International Efforts

Biomax InformaticsThe bioinformatics company Biomax, headquartered in Planegg, Germany, makesitssemantic search platform AILANI available free of charge to research institutes around the world in order to support the rapid and successful search for drugs and suitable vaccinesagainst COVID-19 infections.

Biomax experts have pre-configured AILANI forthe specific needs of researchers in the field of COVID-19 and integrated publicly available literature, data and knowledge.Using AILANI scientists get faster insight in existing knowledge, discover previously unknown associationsand areable to takebetter research decisions.The new search platform is accessible at https://ailani.ai.

Biomax also supports international efforts to collect knowledge with a special text mining system. In this context Biomaxispartner of PREPARE, a platform for European Preparedness against (Re-)Emerging Epidemics,and member of the COVID-19 Disease Map Community, a European program that has beenset up to share resources and best practices to develop a disease map for COVID-19andSARS-CoV-2.

Biomax's expertise in electronic case reporting (eCRF) and the established data integration system BioXM additionally enables the design of an open, comprehensive information network for the collection, management and analysis of data on the COVID-19 epidemic, clinical disease progression or rehabilitation, tohelp physicians find the best treatment for their individual patients.

For further information, please visit:
http://www.biomax.com

About Biomax Informatics

Biomax Informatics provides services and software solutions for efficient decision making and knowledge management at the intersection of life sciences, healthcare and information technologies. Biomax facilitates digital transformation within biotech, pharma,agriculture, food and chemical industries as well as research institutes.

The companylooks back on 20 years of experience and currently employs around 50 people - including numerous life scientists, data scientists and software developers with a scientific background.

Founded in 1997, Biomax Informatics is ISO9001 and ISO27001 certified and is headquartered in Planegg near Munich, Germany.

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...